After the Sydney autumn, races in Brisbane could also feature in Amenable’s program, including the Stradbroke. “I thought he ran very well in it last year,” Elam said.

Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...

Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...

We learn clutch control from day one of the MSF, where we're told that bike clutches are more forgiving than their car ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy – – Follows recently received ...

Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...

Brydon Carse has been ruled out of the rest of England's Champions Trophy campaign, starting with their must-win game against ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy - - Follows recently received ...

This article is published as part of The Telegraph’s Greatest Interviews series, which revisits the most significant, ...

Brydon Carse looks set to be ruled out of the rest of England's Champions Trophy campaign, starting with their must-win game ...

NASD OTC Exchange Plc has said that it recognises the importance of a well-developed solid minerals sector in driving ...

This article focuses on post-pandemic legal developments at the crossroads of the (potential) conflict between employer ...